Osilodrostat: 11β-hydroxylase inhibitor for treatment of Cushing's disease.
Sign Up to like & getrecommendations! Published in 2020 at "Drugs of today"
DOI: 10.1358/dot.2020.56.10.3182908
Abstract: Osilodrostat was synthesized in a search for a drug that would inhibit the synthesis of aldosterone, with the aim to discover a new approach for treating hypertension. However, early clinical trials revealed that the doses… read more here.
Keywords: cushing disease; inhibitor; osilodrostat hydroxylase; hydroxylase inhibitor ... See more keywords